Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer. Li X, Li Y, Zhang L, Long H, et al. BMC Cancer 2024;24:1242.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Li Y, Zhang L, Long H, et al. Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer. BMC Cancer 2024;24:1242.
PMID: 39379919